| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
0.17 |
7e-05 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0002 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.15 |
0.0004 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.18 |
0.0004 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
| mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0009 |